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Getting a handle on centrosomes
 
entrosomes are required for cytokinesis and are important 
in cell cycle progression—but how are centrosomes 
connected to these essential cellular functions at the molecular 
level? On page 535, Gromley et al. describe the maternal cen-
triole protein centriolin, the first integral centrosome pro-
tein linked to both cytokinesis and cell cycle progression in 
vertebrate cells.
Overexpression, siRNA silencing, or antibody inhibition of 
centriolin causes an unusual cytokinesis defect, in which cells 
remain connected by long strands of cytoplasm and form 
syncytia. Some of the cells later undergo cell cycle arrest in 
G1/G0, and some undergo apoptosis. The cytokinesis defect 
is caused by a domain in centriolin that shares homology with 
yeast regulatory proteins in the MEN/SIN pathway, which 
controls yeast mitotic exit and cytokinesis.
The results suggest 
that centriolin links 
centrosomes to a 
critical cytokinesis 
regulatory system 
and possibly to a 
cell cycle check-
point. Screening 
work is now un-
covering additional 
members of the 
cytokinesis pathway. 
Centriolin also con-
tains domains with homology to proteins implicated in human 
tumorigenesis. Since centrosome defects would cause 
aneuploidy, a hallmark of cancer, the authors are now trying to 
determine whether centriolin has oncogenic functions.
 
 
 
 
C
Centriolin deficiency disrupts cytokinesis.
 
The neutrophil as ﬁreﬁghter
 
evere bacterial infection or trauma frequently leads to a 
systemic inflammatory response, a self-reinforcing activation 
of neutrophils and vascular endothelial cells that can be 
deadly. On page 641, Cepinskas et al. describe a neutrophil-
mediated signaling mechanism that inhibits inflammation. 
The findings demonstrate a novel function for neutrophils 
and a previously unknown form of immunological tolerance, 
and they identify a promising target for new anti-inflammatory 
drugs.
In systemic inflammation, circulating cytokines cause the 
transcription factor NF
 
 
 
B to translocate from the cytoplasm 
to the nucleus of vascular endothelial cells, where it induces 
the transcription of pro-inflammatory genes. Using a cell 
culture model of inflammation, the authors found that the 
migration of neutrophils across a monolayer of cytokine-
activated endothelial cells causes NF
 
 
 
B levels in the endothelial 
cell nuclei to drop. Cross-linking the adhesion molecule 
S
 
Breaking down barriers
 
n page 653, Nitta et al. show that removal of the
tight junction component claudin-5 makes the murine 
blood–brain barrier (BBB) selectively permeable to small 
molecules. Although considerably more work is needed before 
this approach can be applied clinically, the finding could be 
a boon for drug delivery to the central nervous system.
 
 
 
Although it was first 
described over a cen-
tury ago, it has been 
shown more recently 
that the BBB consists 
of intercellular tight 
junctions, which pre-
vent most molecules 
in the bloodstream 
from reaching the 
brain. In the new work, 
the authors found that 
the tight junctions of 
the BBB are primarily composed of the membrane proteins 
claudin-5 and claudin-12. Mice with a homozygous deletion 
in the claudin-5 gene appear to develop normally, and do not 
show signs of bleeding or edema, but do exhibit a striking 
abnormality in tracer experiments. Although the BBB of the 
knockout animals still blocks large molecules, it permits 
molecules smaller than 
 
 
 
800 D to pass into the central ner-
vous system.
Unfortunately, all of the claudin-5 knockout mice died 
within ten hours of birth for unknown reasons. The 
authors are now trying to generate conditional deletions 
to characterize the functions of claudin-5 and claudin-12 
in more detail. 
 
 
O
Impairment of the BBB in cluadin-5 
knock-out mice (right).
 
PECAM-1 on the 
surface of the endo-
thelial cells produces 
the same effect, suggest-
ing that the neutrophils 
send anti-inflammatory 
signals to the endo-
thelium through 
PECAM-1. Exposing 
the neutrophil-calmed 
endothelial cells to 
a second round of 
cytokine activation 
Transendothelial migration of neutrophils 
affects the localization of NF B in 
endothelial cells.
 
results in even further reduction of the pro-inflammatory 
response. The authors are now trying to determine what 
controls this novel type of induced tolerance at the molecular 
level.
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